Showing results (281-290 of 386) with videos related to
Sort By:
Pageof 39
Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|April 17, 2007
ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active diseaseAnnette Fox, David J Jeffries, Philip C Hill, et al.Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.Plos One|February 1, 2007
Using ELISPOT to expose false positive skin test conversion in tuberculosis contactsPhilip C Hill, David J Jeffries, Roger H Brookes, et al.NPJ Vaccines|August 25, 2025
Boosting the influenza vaccine schedule in children with cancer: a prospective open-label studySung K Chiu, Eliska Furlong, Elizabeth J McKinnon, et al.Science Immunology|August 6, 2017
Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responsesJingxian Zhao, Abeer N Alshukairi, Salim A Baharoon, et al.The Journal of Infection|March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in AustraliaNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.Mbio|July 21, 2022
Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory ExerciseJessica A Belser, Eric H Y Lau, Wendy Barclay, et al.Pageof 39